Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
11.23
-0.50 (-4.26%)
At close: Nov 10, 2026, 4:00 PM EST
11.23
0.00 (0.00%)
Pre-market: Nov 11, 2026, 7:49 AM EST

Cullinan Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
88.2688.3383.0198.43156.1559.77
Short-Term Investments
201.31289.56315.97368.63311.14230.69
Cash & Short-Term Investments
289.57377.9398.98467.07467.29290.47
Cash Growth
-12.94%-5.28%-14.58%-0.05%60.88%38.18%
Other Receivables
2.32.833---
Receivables
2.32.833---
Prepaid Expenses
6.286.0312.6913.127.186.1
Total Current Assets
298.15386.76414.67480.19474.47296.56
Property, Plant & Equipment
2.213.052.353.535.30.08
Long-Term Investments
21.958.27204.44-80.88140.4
Other Long-Term Assets
0.30.30.370.460.460.15
Total Assets
322.56448.37621.82484.18561.12437.19

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.140.841.682.492.663.17
Accrued Expenses
36.6635.1226.2323.29127.6
Short-Term Debt
----0.18-
Current Portion of Leases
0.860.781.31.441.42-
Current Income Taxes Payable
----4.28-
Other Current Liabilities
1.4711.440.911.960.97
Total Current Liabilities
40.1337.7430.6528.1422.511.75
Long-Term Leases
1.151.90.852.153.59-
Other Long-Term Liabilities
-----0.07
Total Liabilities
41.2839.6431.530.2926.0911.81

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.0100.010
Additional Paid-In Capital
1,023995.82958.7654.69585.32584.71
Retained Earnings
-740.87-588.12-368.24-200.86-47.7-158.91
Comprehensive Income & Other
-0.651.02-0.13-0.13-2.6-0.84
Total Common Equity
281.28408.73590.33453.7535.03424.97
Minority Interest
---0.19-0.4
Shareholders' Equity
281.28408.73590.33453.9535.03425.37
Total Liabilities & Equity
322.56448.37621.82484.18561.12437.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
22.682.153.595.19-
Net Cash (Debt)
287.57375.21396.83463.48462.1290.47
Net Cash Growth
-13.23%-5.45%-14.38%0.30%59.09%38.18%
Net Cash Per Share
4.686.357.3811.159.916.74
Filing Date Shares Outstanding
64.9260.5358.5143.0739.3344.61
Total Common Shares Outstanding
64.960.2458.5142.945.844.29
Working Capital
258.02349.02384.02452.05451.97284.82
Book Value Per Share
4.336.7810.0910.5811.689.59
Tangible Book Value
281.28408.73590.33453.7535.03424.97
Tangible Book Value Per Share
4.336.7810.0910.5811.689.59
Machinery
-0.810.770.770.680.2
Leasehold Improvements
-0.580.580.580.630.11
SEC Filings: 10-K · 10-Q